Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
AUC |
1158.5 |
ng.h/ml |
717-1600 |
ug.h/L |
PO, oral; |
|
DRUGBANK |
AUC |
609.5 |
ng.h/ml |
272-947 |
ug.h/L |
PO, oral; |
|
DRUGBANK |
AUC |
216.5 |
ng.h/ml |
208-225 |
ug.h/L |
|
|
DRUGBANK |
Bioavailability |
30.0 |
% |
25-35 |
% |
PO, oral; |
|
DRUGBANK |
Bioavailability |
25.0 |
% |
25.0 |
% |
PO, oral; |
|
The Pharmacological Basis of Therapeutics |
Bioavailability |
15.0 |
% |
15.0 |
% |
PO, oral; Optical rotation S; |
|
The Pharmacological Basis of Therapeutics |
Bioavailability |
31.0 |
% |
31.0 |
% |
PO, oral; Optical rotation R; |
|
The Pharmacological Basis of Therapeutics |
C Max |
192.0 |
ng/ml |
122-262 |
ug/L |
PO, oral; |
|
DRUGBANK |
C Max |
87.5 |
ng/ml |
24-151 |
ug/L |
PO, oral; |
|
DRUGBANK |
C Max |
63.5 |
ng/ml |
58-69 |
ug/L |
|
|
DRUGBANK |
C Max |
105.0 |
ng/ml |
105±12 |
ng/ml |
PO, oral; adults; normal,healthy; |
|
The Pharmacological Basis of Therapeutics |
T Max |
1.5 |
h |
1-2 |
h |
PO, oral; |
|
DRUGBANK |
T Max |
1.3 |
h |
1.3±0.3 |
h |
PO, oral; adults; normal,healthy; |
|
The Pharmacological Basis of Therapeutics |
Clearance |
0.52 |
L/kg |
0.52 |
L/kg |
Plasma clearance; |
|
DRUGBANK |
Clearance |
0.52 |
L/h/kg |
8.7±1.7 |
ml/min/kg |
|
Elderly → ;Hepatitis, Hep ↓ ;RD, renal impairment, Renal disease,including uremia → ; |
The Pharmacological Basis of Therapeutics |
Clearance |
0.47 |
L/h/kg |
7.8 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
1.8 |
L/kg |
1.5-2 |
L/kg |
|
|
DRUGBANK |
Volume of Distribution |
1.5 |
L/kg |
1.5±0.3 |
L/kg |
|
Hepatitis, Hep ↑ ; |
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
1.3 |
L/kg |
1.3 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Half-life |
8.5 |
h |
7-10 |
h |
|
|
DRUGBANK |
Half-life |
2.2 |
h |
2.2±0.3 |
h |
|
Hepatic cirrhosis, cirr ↑ ;RD, renal impairment, Renal disease,including uremia → ;Age → ; |
The Pharmacological Basis of Therapeutics |
Half-life |
6.0 |
h |
6 |
h |
low concentration; |
|
The Pharmacological Basis of Therapeutics |
Half-life |
2.4 |
h |
2.4 |
h |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
16.0 |
% |
16 |
% |
Urinary excretion; |
|
DRUGBANK |
Eliminate Route |
2.0 |
% |
<2 |
% |
Urinary excretion; Unchanged drug; |
|
The Pharmacological Basis of Therapeutics |
Protein Binding |
98.0 |
% |
98 |
% |
plasma proteins; |
|
DRUGBANK |
Protein Binding |
95.0 |
% |
95 |
% |
|
|
DRUGBANK |
Protein Binding |
95.0 |
% |
95 |
% |
|
|
The Pharmacological Basis of Therapeutics |